img

Global Antiasthmatic Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antiasthmatic Drug Market Insights, Forecast to 2034

Antiasthmatic drugs refer to the drugs that can eliminate chronic airway inflammation, relieve bronchoconstriction and spasm, dilate bronchus and reduce airway hyperresponsiveness.
Market Analysis and InsightsGlobal Antiasthmatic Drug Market
The global Antiasthmatic Drug market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The antiasthmatic drug industry has a large market demand, capital benefits the antiasthmatic drug field, and the industry is developing in a good way in the long term.The transaction scale of the downstream industry increased, providing a new impetus for the development of the antiasthma industry.In addition, the improvement of the consumption level of residents provides economic basis for the market demand of antiasthmatic drugs industry.
Report Includes
This report presents an overview of global market for Antiasthmatic Drug market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Antiasthmatic Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antiasthmatic Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antiasthmatic Drug revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Antiasthmatic Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Antiasthmatic Drug revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis AG, GlaxoSmithKline, ABC Farmaceutici Spa, AstraZeneca, Teva Pharmaceutical Industries Ltd, Mundipharma Pharmaceuticals Ltd., MSD, Daiichi Sankyo Company Limited and Chiesi GmbH, etc.



By Company


Novartis AG
GlaxoSmithKline
ABC Farmaceutici Spa
AstraZeneca
Teva Pharmaceutical Industries Ltd
Mundipharma Pharmaceuticals Ltd.
MSD
Daiichi Sankyo Company Limited
Chiesi GmbH
Kyorin Pharmaceutical Co.,Ltd.
Kissei Pharmaceutical Co.Ltd.
Ruiyang Pharmaceutical Co., Ltd
Chiesi Pharmaceutical (Shangai) Co., Ltd
Fuhe Group
Lunan Pharmaceutical Group Co., Ltd
Chengdu Huayu Pharmaceutical Co., Ltd
Kaifeng Kangnuo Pharmaceutical Co., Ltd
Akorn Pharmaceutical Co.Ltd.
Boehringer Ingelheim Pharma GmbH&Co.KG
Covis Pharmaceutical Inc
Roche
Segment by Type
Bronchodilators
Anti-allergic Antiasthmatic
Anti-inflammatory Antiasthmatic

Segment by Application


Need for Acute Attack of Asthma
Treatment of Chronic Asthma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Antiasthmatic Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Antiasthmatic Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antiasthmatic Drug revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiasthmatic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Bronchodilators
1.2.3 Anti-allergic Antiasthmatic
1.2.4 Anti-inflammatory Antiasthmatic
1.3 Market by Application
1.3.1 Global Antiasthmatic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Need for Acute Attack of Asthma
1.3.3 Treatment of Chronic Asthma
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiasthmatic Drug Market Perspective (2018-2034)
2.2 Global Antiasthmatic Drug Growth Trends by Region
2.2.1 Antiasthmatic Drug Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Antiasthmatic Drug Historic Market Size by Region (2018-2024)
2.2.3 Antiasthmatic Drug Forecasted Market Size by Region (2024-2034)
2.3 Antiasthmatic Drug Market Dynamics
2.3.1 Antiasthmatic Drug Industry Trends
2.3.2 Antiasthmatic Drug Market Drivers
2.3.3 Antiasthmatic Drug Market Challenges
2.3.4 Antiasthmatic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Antiasthmatic Drug by Players
3.1.1 Global Antiasthmatic Drug Revenue by Players (2018-2024)
3.1.2 Global Antiasthmatic Drug Revenue Market Share by Players (2018-2024)
3.2 Global Antiasthmatic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Antiasthmatic Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Antiasthmatic Drug Market Concentration Ratio
3.4.1 Global Antiasthmatic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiasthmatic Drug Revenue in 2022
3.5 Global Key Players of Antiasthmatic Drug Head office and Area Served
3.6 Global Key Players of Antiasthmatic Drug, Product and Application
3.7 Global Key Players of Antiasthmatic Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiasthmatic Drug Breakdown Data by Type
4.1 Global Antiasthmatic Drug Historic Market Size by Type (2018-2024)
4.2 Global Antiasthmatic Drug Forecasted Market Size by Type (2024-2034)
5 Antiasthmatic Drug Breakdown Data by Application
5.1 Global Antiasthmatic Drug Historic Market Size by Application (2018-2024)
5.2 Global Antiasthmatic Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Antiasthmatic Drug Market Size (2018-2034)
6.2 North America Antiasthmatic Drug Market Size by Type
6.2.1 North America Antiasthmatic Drug Market Size by Type (2018-2024)
6.2.2 North America Antiasthmatic Drug Market Size by Type (2024-2034)
6.2.3 North America Antiasthmatic Drug Market Share by Type (2018-2034)
6.3 North America Antiasthmatic Drug Market Size by Application
6.3.1 North America Antiasthmatic Drug Market Size by Application (2018-2024)
6.3.2 North America Antiasthmatic Drug Market Size by Application (2024-2034)
6.3.3 North America Antiasthmatic Drug Market Share by Application (2018-2034)
6.4 North America Antiasthmatic Drug Market Size by Country
6.4.1 North America Antiasthmatic Drug Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Antiasthmatic Drug Market Size by Country (2018-2024)
6.4.3 North America Antiasthmatic Drug Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Antiasthmatic Drug Market Size (2018-2034)
7.2 Europe Antiasthmatic Drug Market Size by Type
7.2.1 Europe Antiasthmatic Drug Market Size by Type (2018-2024)
7.2.2 Europe Antiasthmatic Drug Market Size by Type (2024-2034)
7.2.3 Europe Antiasthmatic Drug Market Share by Type (2018-2034)
7.3 Europe Antiasthmatic Drug Market Size by Application
7.3.1 Europe Antiasthmatic Drug Market Size by Application (2018-2024)
7.3.2 Europe Antiasthmatic Drug Market Size by Application (2024-2034)
7.3.3 Europe Antiasthmatic Drug Market Share by Application (2018-2034)
7.4 Europe Antiasthmatic Drug Market Size by Country
7.4.1 Europe Antiasthmatic Drug Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Antiasthmatic Drug Market Size by Country (2018-2024)
7.4.3 Europe Antiasthmatic Drug Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Antiasthmatic Drug Market Size (2018-2034)
8.2 China Antiasthmatic Drug Market Size by Type
8.2.1 China Antiasthmatic Drug Market Size by Type (2018-2024)
8.2.2 China Antiasthmatic Drug Market Size by Type (2024-2034)
8.2.3 China Antiasthmatic Drug Market Share by Type (2018-2034)
8.3 China Antiasthmatic Drug Market Size by Application
8.3.1 China Antiasthmatic Drug Market Size by Application (2018-2024)
8.3.2 China Antiasthmatic Drug Market Size by Application (2024-2034)
8.3.3 China Antiasthmatic Drug Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Antiasthmatic Drug Market Size (2018-2034)
9.2 Asia Antiasthmatic Drug Market Size by Type
9.2.1 Asia Antiasthmatic Drug Market Size by Type (2018-2024)
9.2.2 Asia Antiasthmatic Drug Market Size by Type (2024-2034)
9.2.3 Asia Antiasthmatic Drug Market Share by Type (2018-2034)
9.3 Asia Antiasthmatic Drug Market Size by Application
9.3.1 Asia Antiasthmatic Drug Market Size by Application (2018-2024)
9.3.2 Asia Antiasthmatic Drug Market Size by Application (2024-2034)
9.3.3 Asia Antiasthmatic Drug Market Share by Application (2018-2034)
9.4 Asia Antiasthmatic Drug Market Size by Region
9.4.1 Asia Antiasthmatic Drug Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Antiasthmatic Drug Market Size by Region (2018-2024)
9.4.3 Asia Antiasthmatic Drug Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Antiasthmatic Drug Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Antiasthmatic Drug Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Antiasthmatic Drug Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Antiasthmatic Drug Introduction
11.1.4 Novartis AG Revenue in Antiasthmatic Drug Business (2018-2024)
11.1.5 Novartis AG Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Antiasthmatic Drug Introduction
11.2.4 GlaxoSmithKline Revenue in Antiasthmatic Drug Business (2018-2024)
11.2.5 GlaxoSmithKline Recent Developments
11.3 ABC Farmaceutici Spa
11.3.1 ABC Farmaceutici Spa Company Details
11.3.2 ABC Farmaceutici Spa Business Overview
11.3.3 ABC Farmaceutici Spa Antiasthmatic Drug Introduction
11.3.4 ABC Farmaceutici Spa Revenue in Antiasthmatic Drug Business (2018-2024)
11.3.5 ABC Farmaceutici Spa Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Antiasthmatic Drug Introduction
11.4.4 AstraZeneca Revenue in Antiasthmatic Drug Business (2018-2024)
11.4.5 AstraZeneca Recent Developments
11.5 Teva Pharmaceutical Industries Ltd
11.5.1 Teva Pharmaceutical Industries Ltd Company Details
11.5.2 Teva Pharmaceutical Industries Ltd Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Introduction
11.5.4 Teva Pharmaceutical Industries Ltd Revenue in Antiasthmatic Drug Business (2018-2024)
11.5.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.6 Mundipharma Pharmaceuticals Ltd.
11.6.1 Mundipharma Pharmaceuticals Ltd. Company Details
11.6.2 Mundipharma Pharmaceuticals Ltd. Business Overview
11.6.3 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Introduction
11.6.4 Mundipharma Pharmaceuticals Ltd. Revenue in Antiasthmatic Drug Business (2018-2024)
11.6.5 Mundipharma Pharmaceuticals Ltd. Recent Developments
11.7 MSD
11.7.1 MSD Company Details
11.7.2 MSD Business Overview
11.7.3 MSD Antiasthmatic Drug Introduction
11.7.4 MSD Revenue in Antiasthmatic Drug Business (2018-2024)
11.7.5 MSD Recent Developments
11.8 Daiichi Sankyo Company Limited
11.8.1 Daiichi Sankyo Company Limited Company Details
11.8.2 Daiichi Sankyo Company Limited Business Overview
11.8.3 Daiichi Sankyo Company Limited Antiasthmatic Drug Introduction
11.8.4 Daiichi Sankyo Company Limited Revenue in Antiasthmatic Drug Business (2018-2024)
11.8.5 Daiichi Sankyo Company Limited Recent Developments
11.9 Chiesi GmbH
11.9.1 Chiesi GmbH Company Details
11.9.2 Chiesi GmbH Business Overview
11.9.3 Chiesi GmbH Antiasthmatic Drug Introduction
11.9.4 Chiesi GmbH Revenue in Antiasthmatic Drug Business (2018-2024)
11.9.5 Chiesi GmbH Recent Developments
11.10 Kyorin Pharmaceutical Co.,Ltd.
11.10.1 Kyorin Pharmaceutical Co.,Ltd. Company Details
11.10.2 Kyorin Pharmaceutical Co.,Ltd. Business Overview
11.10.3 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Introduction
11.10.4 Kyorin Pharmaceutical Co.,Ltd. Revenue in Antiasthmatic Drug Business (2018-2024)
11.10.5 Kyorin Pharmaceutical Co.,Ltd. Recent Developments
11.11 Kissei Pharmaceutical Co.Ltd.
11.11.1 Kissei Pharmaceutical Co.Ltd. Company Details
11.11.2 Kissei Pharmaceutical Co.Ltd. Business Overview
11.11.3 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Introduction
11.11.4 Kissei Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2018-2024)
11.11.5 Kissei Pharmaceutical Co.Ltd. Recent Developments
11.12 Ruiyang Pharmaceutical Co., Ltd
11.12.1 Ruiyang Pharmaceutical Co., Ltd Company Details
11.12.2 Ruiyang Pharmaceutical Co., Ltd Business Overview
11.12.3 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Introduction
11.12.4 Ruiyang Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2018-2024)
11.12.5 Ruiyang Pharmaceutical Co., Ltd Recent Developments
11.13 Chiesi Pharmaceutical (Shangai) Co., Ltd
11.13.1 Chiesi Pharmaceutical (Shangai) Co., Ltd Company Details
11.13.2 Chiesi Pharmaceutical (Shangai) Co., Ltd Business Overview
11.13.3 Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Introduction
11.13.4 Chiesi Pharmaceutical (Shangai) Co., Ltd Revenue in Antiasthmatic Drug Business (2018-2024)
11.13.5 Chiesi Pharmaceutical (Shangai) Co., Ltd Recent Developments
11.14 Fuhe Group
11.14.1 Fuhe Group Company Details
11.14.2 Fuhe Group Business Overview
11.14.3 Fuhe Group Antiasthmatic Drug Introduction
11.14.4 Fuhe Group Revenue in Antiasthmatic Drug Business (2018-2024)
11.14.5 Fuhe Group Recent Developments
11.15 Lunan Pharmaceutical Group Co., Ltd
11.15.1 Lunan Pharmaceutical Group Co., Ltd Company Details
11.15.2 Lunan Pharmaceutical Group Co., Ltd Business Overview
11.15.3 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Introduction
11.15.4 Lunan Pharmaceutical Group Co., Ltd Revenue in Antiasthmatic Drug Business (2018-2024)
11.15.5 Lunan Pharmaceutical Group Co., Ltd Recent Developments
11.16 Chengdu Huayu Pharmaceutical Co., Ltd
11.16.1 Chengdu Huayu Pharmaceutical Co., Ltd Company Details
11.16.2 Chengdu Huayu Pharmaceutical Co., Ltd Business Overview
11.16.3 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Introduction
11.16.4 Chengdu Huayu Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2018-2024)
11.16.5 Chengdu Huayu Pharmaceutical Co., Ltd Recent Developments
11.17 Kaifeng Kangnuo Pharmaceutical Co., Ltd
11.17.1 Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Details
11.17.2 Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview
11.17.3 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Introduction
11.17.4 Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2018-2024)
11.17.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Developments
11.18 Akorn Pharmaceutical Co.Ltd.
11.18.1 Akorn Pharmaceutical Co.Ltd. Company Details
11.18.2 Akorn Pharmaceutical Co.Ltd. Business Overview
11.18.3 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Introduction
11.18.4 Akorn Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2018-2024)
11.18.5 Akorn Pharmaceutical Co.Ltd. Recent Developments
11.19 Boehringer Ingelheim Pharma GmbH&Co.KG
11.19.1 Boehringer Ingelheim Pharma GmbH&Co.KG Company Details
11.19.2 Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview
11.19.3 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Introduction
11.19.4 Boehringer Ingelheim Pharma GmbH&Co.KG Revenue in Antiasthmatic Drug Business (2018-2024)
11.19.5 Boehringer Ingelheim Pharma GmbH&Co.KG Recent Developments
11.20 Covis Pharmaceutical Inc
11.20.1 Covis Pharmaceutical Inc Company Details
11.20.2 Covis Pharmaceutical Inc Business Overview
11.20.3 Covis Pharmaceutical Inc Antiasthmatic Drug Introduction
11.20.4 Covis Pharmaceutical Inc Revenue in Antiasthmatic Drug Business (2018-2024)
11.20.5 Covis Pharmaceutical Inc Recent Developments
11.21 Roche
11.21.1 Roche Company Details
11.21.2 Roche Business Overview
11.21.3 Roche Antiasthmatic Drug Introduction
11.21.4 Roche Revenue in Antiasthmatic Drug Business (2018-2024)
11.21.5 Roche Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Antiasthmatic Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Anti-allergic Antiasthmatic
Table 4. Key Players of Anti-inflammatory Antiasthmatic
Table 5. Global Antiasthmatic Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 6. Global Antiasthmatic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Antiasthmatic Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Antiasthmatic Drug Market Share by Region (2018-2024)
Table 9. Global Antiasthmatic Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Antiasthmatic Drug Market Share by Region (2024-2034)
Table 11. Antiasthmatic Drug Market Trends
Table 12. Antiasthmatic Drug Market Drivers
Table 13. Antiasthmatic Drug Market Challenges
Table 14. Antiasthmatic Drug Market Restraints
Table 15. Global Antiasthmatic Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Antiasthmatic Drug Revenue Share by Players (2018-2024)
Table 17. Global Top Antiasthmatic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiasthmatic Drug as of 2022)
Table 18. Global Antiasthmatic Drug Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Antiasthmatic Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Antiasthmatic Drug, Headquarters and Area Served
Table 21. Global Key Players of Antiasthmatic Drug, Product and Application
Table 22. Global Key Players of Antiasthmatic Drug, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antiasthmatic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Antiasthmatic Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Antiasthmatic Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Antiasthmatic Drug Revenue Market Share by Type (2024-2034)
Table 28. Global Antiasthmatic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Antiasthmatic Drug Revenue Share by Application (2018-2024)
Table 30. Global Antiasthmatic Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Antiasthmatic Drug Revenue Share by Application (2024-2034)
Table 32. North America Antiasthmatic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Antiasthmatic Drug Market Size by Type (2024-2034) & (US$ Million)
Table 34. North America Antiasthmatic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Antiasthmatic Drug Market Size by Application (2024-2034) & (US$ Million)
Table 36. North America Antiasthmatic Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 37. North America Antiasthmatic Drug Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Antiasthmatic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. Europe Antiasthmatic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Antiasthmatic Drug Market Size by Type (2024-2034) & (US$ Million)
Table 41. Europe Antiasthmatic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Antiasthmatic Drug Market Size by Application (2024-2034) & (US$ Million)
Table 43. Europe Antiasthmatic Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 44. Europe Antiasthmatic Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Antiasthmatic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 46. China Antiasthmatic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Antiasthmatic Drug Market Size by Type (2024-2034) & (US$ Million)
Table 48. China Antiasthmatic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Antiasthmatic Drug Market Size by Application (2024-2034) & (US$ Million)
Table 50. Asia Antiasthmatic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Antiasthmatic Drug Market Size by Type (2024-2034) & (US$ Million)
Table 52. Asia Antiasthmatic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Antiasthmatic Drug Market Size by Application (2024-2034) & (US$ Million)
Table 54. Asia Antiasthmatic Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 55. Asia Antiasthmatic Drug Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Antiasthmatic Drug Market Size by Region (2024-2034) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Type (2024-2034) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Application (2024-2034) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Antiasthmatic Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 62. Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Antiasthmatic Drug Market Size by Country (2024-2034) & (US$ Million)
Table 64. Novartis AG Company Details
Table 65. Novartis AG Business Overview
Table 66. Novartis AG Antiasthmatic Drug Product
Table 67. Novartis AG Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 68. Novartis AG Recent Developments
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Antiasthmatic Drug Product
Table 72. GlaxoSmithKline Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 73. GlaxoSmithKline Recent Developments
Table 74. ABC Farmaceutici Spa Company Details
Table 75. ABC Farmaceutici Spa Business Overview
Table 76. ABC Farmaceutici Spa Antiasthmatic Drug Product
Table 77. ABC Farmaceutici Spa Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 78. ABC Farmaceutici Spa Recent Developments
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Antiasthmatic Drug Product
Table 82. AstraZeneca Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 83. AstraZeneca Recent Developments
Table 84. Teva Pharmaceutical Industries Ltd Company Details
Table 85. Teva Pharmaceutical Industries Ltd Business Overview
Table 86. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product
Table 87. Teva Pharmaceutical Industries Ltd Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 88. Teva Pharmaceutical Industries Ltd Recent Developments
Table 89. Mundipharma Pharmaceuticals Ltd. Company Details
Table 90. Mundipharma Pharmaceuticals Ltd. Business Overview
Table 91. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product
Table 92. Mundipharma Pharmaceuticals Ltd. Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 93. Mundipharma Pharmaceuticals Ltd. Recent Developments
Table 94. MSD Company Details
Table 95. MSD Business Overview
Table 96. MSD Antiasthmatic Drug Product
Table 97. MSD Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 98. MSD Recent Developments
Table 99. Daiichi Sankyo Company Limited Company Details
Table 100. Daiichi Sankyo Company Limited Business Overview
Table 101. Daiichi Sankyo Company Limited Antiasthmatic Drug Product
Table 102. Daiichi Sankyo Company Limited Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 103. Daiichi Sankyo Company Limited Recent Developments
Table 104. Chiesi GmbH Company Details
Table 105. Chiesi GmbH Business Overview
Table 106. Chiesi GmbH Antiasthmatic Drug Product
Table 107. Chiesi GmbH Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 108. Chiesi GmbH Recent Developments
Table 109. Kyorin Pharmaceutical Co.,Ltd. Company Details
Table 110. Kyorin Pharmaceutical Co.,Ltd. Business Overview
Table 111. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product
Table 112. Kyorin Pharmaceutical Co.,Ltd. Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 113. Kyorin Pharmaceutical Co.,Ltd. Recent Developments
Table 114. Kissei Pharmaceutical Co.Ltd. Company Details
Table 115. Kissei Pharmaceutical Co.Ltd. Business Overview
Table 116. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product
Table 117. Kissei Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 118. Kissei Pharmaceutical Co.Ltd. Recent Developments
Table 119. Ruiyang Pharmaceutical Co., Ltd Company Details
Table 120. Ruiyang Pharmaceutical Co., Ltd Business Overview
Table 121. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product
Table 122. Ruiyang Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 123. Ruiyang Pharmaceutical Co., Ltd Recent Developments
Table 124. Chiesi Pharmaceutical (Shangai) Co., Ltd Company Details
Table 125. Chiesi Pharmaceutical (Shangai) Co., Ltd Business Overview
Table 126. Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Product
Table 127. Chiesi Pharmaceutical (Shangai) Co., Ltd Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 128. Chiesi Pharmaceutical (Shangai) Co., Ltd Recent Developments
Table 129. Fuhe Group Company Details
Table 130. Fuhe Group Business Overview
Table 131. Fuhe Group Antiasthmatic Drug Product
Table 132. Fuhe Group Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 133. Fuhe Group Recent Developments
Table 134. Lunan Pharmaceutical Group Co., Ltd Company Details
Table 135. Lunan Pharmaceutical Group Co., Ltd Business Overview
Table 136. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product
Table 137. Lunan Pharmaceutical Group Co., Ltd Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 138. Lunan Pharmaceutical Group Co., Ltd Recent Developments
Table 139. Chengdu Huayu Pharmaceutical Co., Ltd Company Details
Table 140. Chengdu Huayu Pharmaceutical Co., Ltd Business Overview
Table 141. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product
Table 142. Chengdu Huayu Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 143. Chengdu Huayu Pharmaceutical Co., Ltd Recent Developments
Table 144. Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Details
Table 145. Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview
Table 146. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product
Table 147. Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 148. Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Developments
Table 149. Akorn Pharmaceutical Co.Ltd. Company Details
Table 150. Akorn Pharmaceutical Co.Ltd. Business Overview
Table 151. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product
Table 152. Akorn Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 153. Akorn Pharmaceutical Co.Ltd. Recent Developments
Table 154. Boehringer Ingelheim Pharma GmbH&Co.KG Company Details
Table 155. Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview
Table 156. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product
Table 157. Boehringer Ingelheim Pharma GmbH&Co.KG Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 158. Boehringer Ingelheim Pharma GmbH&Co.KG Recent Developments
Table 159. Covis Pharmaceutical Inc Company Details
Table 160. Covis Pharmaceutical Inc Business Overview
Table 161. Covis Pharmaceutical Inc Antiasthmatic Drug Product
Table 162. Covis Pharmaceutical Inc Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 163. Covis Pharmaceutical Inc Recent Developments
Table 164. Roche Company Details
Table 165. Roche Business Overview
Table 166. Roche Antiasthmatic Drug Product
Table 167. Roche Revenue in Antiasthmatic Drug Business (2018-2024) & (US$ Million)
Table 168. Roche Recent Developments
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiasthmatic Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Antiasthmatic Drug Market Share by Type: 2022 VS 2034
Figure 3. Bronchodilators Features
Figure 4. Anti-allergic Antiasthmatic Features
Figure 5. Anti-inflammatory Antiasthmatic Features
Figure 6. Global Antiasthmatic Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Antiasthmatic Drug Market Share by Application: 2022 VS 2034
Figure 8. Need for Acute Attack of Asthma Case Studies
Figure 9. Treatment of Chronic Asthma Case Studies
Figure 10. Antiasthmatic Drug Report Years Considered
Figure 11. Global Antiasthmatic Drug Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global Antiasthmatic Drug Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Antiasthmatic Drug Market Share by Region: 2022 VS 2034
Figure 14. Global Antiasthmatic Drug Market Share by Players in 2022
Figure 15. Global Top Antiasthmatic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiasthmatic Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Antiasthmatic Drug Revenue in 2022
Figure 17. North America Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America Antiasthmatic Drug Market Share by Type (2018-2034)
Figure 19. North America Antiasthmatic Drug Market Share by Application (2018-2034)
Figure 20. North America Antiasthmatic Drug Market Share by Country (2018-2034)
Figure 21. United States Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Antiasthmatic Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 24. Europe Antiasthmatic Drug Market Share by Type (2018-2034)
Figure 25. Europe Antiasthmatic Drug Market Share by Application (2018-2034)
Figure 26. Europe Antiasthmatic Drug Market Share by Country (2018-2034)
Figure 27. Germany Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. France Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. U.K. Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Italy Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Russia Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Nordic Countries Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. China Antiasthmatic Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 34. China Antiasthmatic Drug Market Share by Type (2018-2034)
Figure 35. China Antiasthmatic Drug Market Share by Application (2018-2034)
Figure 36. Asia Antiasthmatic Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 37. Asia Antiasthmatic Drug Market Share by Type (2018-2034)
Figure 38. Asia Antiasthmatic Drug Market Share by Application (2018-2034)
Figure 39. Asia Antiasthmatic Drug Market Share by Region (2018-2034)
Figure 40. Japan Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. South Korea Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. China Taiwan Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Southeast Asia Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. India Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Australia Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Antiasthmatic Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Antiasthmatic Drug Market Share by Type (2018-2034)
Figure 48. Middle East, Africa, and Latin America Antiasthmatic Drug Market Share by Application (2018-2034)
Figure 49. Middle East, Africa, and Latin America Antiasthmatic Drug Market Share by Country (2018-2034)
Figure 50. Brazil Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. Mexico Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Turkey Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Israel Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. GCC Countries Antiasthmatic Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Novartis AG Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 58. ABC Farmaceutici Spa Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 59. AstraZeneca Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 60. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 61. Mundipharma Pharmaceuticals Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 62. MSD Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 63. Daiichi Sankyo Company Limited Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 64. Chiesi GmbH Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 65. Kyorin Pharmaceutical Co.,Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 66. Kissei Pharmaceutical Co.Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 67. Ruiyang Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 68. Chiesi Pharmaceutical (Shangai) Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 69. Fuhe Group Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 70. Lunan Pharmaceutical Group Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 71. Chengdu Huayu Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 72. Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 73. Akorn Pharmaceutical Co.Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 74. Boehringer Ingelheim Pharma GmbH&Co.KG Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 75. Covis Pharmaceutical Inc Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 76. Roche Revenue Growth Rate in Antiasthmatic Drug Business (2018-2024)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries